{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:57:48Z","timestamp":1795150668375,"version":"4.10.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["CU_GR_63_137_30_44"],"award-info":[{"award-number":["CU_GR_63_137_30_44"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["CU_GR_63_137_30_44"],"award-info":[{"award-number":["CU_GR_63_137_30_44"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["CU_GR_63_137_30_44"],"award-info":[{"award-number":["CU_GR_63_137_30_44"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose:<\/jats:title>\n                <jats:p>The aim of this study was to develop a normal tissue complication probability model using a machine learning approach (ML-based NTCP) to predict the risk of radiation-induced liver disease in hepatocellular carcinoma (HCC) patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods:<\/jats:title>\n                <jats:p>The study population included 201 HCC patients treated with radiotherapy. The patients\u2019 medical records were retrospectively reviewed to obtain the clinical and radiotherapy data. Toxicity was defined by albumin-bilirubin (ALBI) grade increase. The normal liver dose-volume histogram was reduced to mean liver dose (MLD) based on the fraction size-adjusted equivalent uniform dose (2\u00a0Gy\/fraction and \u03b1\/\u03b2\u2009=\u20092). Three types of ML-based classification models were used, a penalized logistic regression (PLR), random forest (RF), and gradient-boosted tree (GBT) model. Model performance was compared using the area under the receiver operating characteristic curve (AUROC). Internal validation was performed by 5-fold cross validation and external validation was done in 44 new patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results:<\/jats:title>\n                <jats:p>Liver toxicity occurred in 87 patients (43.1%). The best individual model was the GBT model using baseline liver function, liver volume, and MLD as inputs and the best overall model was an ensemble of the PLR and GBT models. An AUROC of 0.82 with a standard deviation of 0.06 was achieved for the internal validation. An AUROC of 0.78 with a standard deviation of 0.03 was achieved for the external validation. The behaviors of the best GBT model were also in good agreement with the domain knowledge on NTCP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion:<\/jats:title>\n                <jats:p>We propose the methodology to develop an ML-based NTCP model to estimate the risk of ALBI grade increase.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-022-02138-8","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T18:02:37Z","timestamp":1670436157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients"],"prefix":"10.1186","volume":"17","author":[{"given":"Anussara","family":"Prayongrat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natchalee","family":"Srimaneekarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokporn","family":"Thonglert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonlakiet","family":"Khorprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napapat","family":"Amornwichet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petch","family":"Alisanant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Shirato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sira","family":"Sriswasdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"issue":"3","key":"2138_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2138_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.prro.2021.09.004","volume":"12","author":"S Apisarnthanarax","year":"2022","unstructured":"Apisarnthanarax S, Barry A, Cao M, Czito B, DeMatteo R, Drinane M, et al. External beam radiation therapy for primary liver cancers: An ASTRO clinical practice guideline. Pract Radiat Oncol. 2022;12(1):28\u201351.","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"2138_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jamaoncol.2017.5847","volume":"4","author":"SM Yoon","year":"2018","unstructured":"Yoon SM, Ryoo BY, Lee SJ, Kim JH, Shin JH, An JH, et al. Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: A randomized clinical trial. JAMA Oncol. 2018;4(5):661\u20139.","journal-title":"JAMA Oncol"},{"issue":"9","key":"2138_CR4","doi-asserted-by":"publisher","first-page":"e0257556","DOI":"10.1371\/journal.pone.0257556","volume":"16","author":"C Khorprasert","year":"2021","unstructured":"Khorprasert C, Thonglert K, Alisanant P, Amornwichet N. Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: Feasibility and clinical outcomes. PLoS ONE. 2021;16(9):e0257556.","journal-title":"PLoS ONE"},{"issue":"3 Suppl","key":"2138_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijrobp.2009.06.092","volume":"76","author":"CC Pan","year":"2010","unstructured":"Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M, et al. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):94\u2013100.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2138_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.semradonc.2017.04.002","volume":"27","author":"P Munoz-Schuffenegger","year":"2017","unstructured":"Munoz-Schuffenegger P, Ng S, Dawson LA. Radiation-induced liver toxicity. Semin Radiat Oncol. 2017;27(4):350\u20137.","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"2138_CR7","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/0360-3016(94)00418-K","volume":"31","author":"TS Lawrence","year":"1995","unstructured":"Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31(5):1237\u201348.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"29","key":"2138_CR8","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1200\/JCO.2008.18.2931","volume":"26","author":"RF Khozouz","year":"2008","unstructured":"Khozouz RF, Huq SZ, Perry MC. Radiation-induced liver disease. J Clin Oncol. 2008;26(29):4844\u20135.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2138_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.semradonc.2018.06.007","volume":"28","author":"EJ Koay","year":"2018","unstructured":"Koay EJ, Owen D, Das P. Radiation-induced liver disease and modern radiotherapy. Semin Radiat Oncol. 2018;28(4):321\u201331.","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"2138_CR10","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ijrobp.2020.04.027","volume":"107","author":"J Pursley","year":"2020","unstructured":"Pursley J, El Naqa I, Sanford NN, Noe B, Wo JY, Eyler CE, et al. Dosimetric analysis and normal-tissue complication probability modeling of Child-Pugh score and Albumin-Bilirubin grade increase after hepatic irradiation. Int J Radiat Oncol Biol Phys. 2020;107(5):986\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2138_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550\u20138.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2138_CR12","doi-asserted-by":"publisher","first-page":"e0216173","DOI":"10.1371\/journal.pone.0216173","volume":"14","author":"SK Lee","year":"2019","unstructured":"Lee SK, Song MJ, Kim SH, Park M. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study. PLoS ONE. 2019;14(5):e0216173.","journal-title":"PLoS ONE"},{"issue":"48","key":"2138_CR13","doi-asserted-by":"publisher","first-page":"28818","DOI":"10.18632\/oncotarget.25522","volume":"9","author":"CHM Ho","year":"2018","unstructured":"Ho CHM, Chiang CL, Lee FAS, Choi HCW, Chan JCH, Yeung CSY, et al. Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT). Oncotarget. 2018;9(48):28818\u201329.","journal-title":"Oncotarget"},{"issue":"1","key":"2138_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13014-019-1251-y","volume":"14","author":"TS Su","year":"2019","unstructured":"Su TS, Yang HM, Zhou Y, Huang Y, Liang P, Cheng T, et al. Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy. Radiat Oncol. 2019;14(1):50.","journal-title":"Radiat Oncol"},{"issue":"3","key":"2138_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.prro.2016.10.003","volume":"7","author":"DAS Toesca","year":"2017","unstructured":"Toesca DAS, Osmundson EC, von Eyben R, Shaffer JL, Koong AC, Chang DT. Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer. Pract Radiat Oncol. 2017;7(3):173\u201382.","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"2138_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109\u201322.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2138_CR17","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/0360-3016(89)90972-3","volume":"16","author":"GJ Kutcher","year":"1989","unstructured":"Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys. 1989;16(6):1623\u201330.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2138_CR18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","volume":"53","author":"LA Dawson","year":"2002","unstructured":"Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002;53(4):810\u201321.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2138_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0360-3016(02)02915-2","volume":"54","author":"JC Cheng","year":"2002","unstructured":"Cheng JC, Wu JK, Huang CM, Liu HS, Huang DY, Cheng SH, et al. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication. Int J Radiat Oncol Biol Phys. 2002;54(1):156\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2138_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijrobp.2005.11.034","volume":"65","author":"ZY Xu","year":"2006","unstructured":"Xu ZY, Liang SX, Zhu J, Zhu XD, Zhao JD, Lu HJ, et al. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys. 2006;65(1):189\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2138_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ijrobp.2006.08.015","volume":"67","author":"TH Kim","year":"2007","unstructured":"Kim TH, Kim DY, Park JW, Kim SH, Choi JI, Kim HB, et al. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67(1):225\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2138_CR22","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3389\/fonc.2020.00790","volume":"10","author":"LJ Isaksson","year":"2020","unstructured":"Isaksson LJ, Pepa M, Zaffaroni M, Marvaso G, Alterio D, Volpe S, et al. Machine learning-based models for prediction of toxicity outcomes in radiotherapy. Front Oncol. 2020;10:790.","journal-title":"Front Oncol"},{"issue":"3","key":"2138_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/jrr\/rrab011","volume":"62","author":"A Prayongrat","year":"2021","unstructured":"Prayongrat A, Srimaneekarn N, Sriswasdi S, Ito YM, Katoh N, Tamura M, et al. Assessment of the confidence interval in the multivariable normal tissue complication probability model for predicting radiation-induced liver disease in primary liver cancer. J Radiat Res. 2021;62(3):483\u201393.","journal-title":"J Radiat Res"},{"issue":"Suppl 1","key":"2138_CR24","first-page":"63-s8","volume":"27","author":"C Parkinson","year":"2021","unstructured":"Parkinson C, Matthams C, Foley K, Spezi E. Artificial intelligence in radiation oncology: A review of its current status and potential application for the radiotherapy workforce. Radiography. 2021;27(Suppl 1):63-s8.","journal-title":"Radiography"},{"issue":"10","key":"2138_CR25","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1002\/mp.13122","volume":"45","author":"B Ibragimov","year":"2018","unstructured":"Ibragimov B, Toesca D, Chang D, Yuan Y, Koong A, Xing L. Development of deep neural network for individualized hepatobiliary toxicity prediction after liver SBRT. Med Phys. 2018;45(10):4763\u201374.","journal-title":"Med Phys"},{"issue":"3 Suppl","key":"2138_CR26","first-page":"10-S9","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):10-S9.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2138_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1118\/1.598063","volume":"24","author":"A Niemierko","year":"1997","unstructured":"Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 1997;24(1):103\u201310.","journal-title":"Med Phys"},{"issue":"3","key":"2138_CR28","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1118\/1.3685447","volume":"39","author":"X Allen Li","year":"2012","unstructured":"Allen Li X, Alber M, Deasy JO, Jackson A, Ken Jee KW, Marks LB, et al. The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys. 2012;39(3):1386\u2013409.","journal-title":"Med Phys"},{"key":"2138_CR29","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting System. Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining. San Francisco, California, USA: New York, NY, USA: ACM; 2016.p.\u00a0785 \u2013 94.","DOI":"10.1145\/2939672.2939785"},{"issue":"3","key":"2138_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","volume":"107","author":"JA Langendijk","year":"2013","unstructured":"Langendijk JA, Lambin P, De Ruysscher D, Widder J, Bos M, Verheij M. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiother Oncol. 2013;107(3):267\u201373.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2138_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.radonc.2011.11.006","volume":"105","author":"I Beetz","year":"2012","unstructured":"Beetz I, Schilstra C, van Luijk P, Christianen ME, Doornaert P, Bijl HP, et al. External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy. Radiother Oncol. 2012;105(1):94\u2013100.","journal-title":"Radiother Oncol"},{"key":"2138_CR32","doi-asserted-by":"publisher","first-page":"616027","DOI":"10.3389\/fonc.2021.616027","volume":"11","author":"L Boldrini","year":"2021","unstructured":"Boldrini L, Corradini S, Gani C, Henke L, Hosni A, Romano A, et al. MR-guided radiotherapy for liver malignancies. Front Oncol. 2021;11:616027.","journal-title":"Front Oncol"},{"issue":"6","key":"2138_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1667\/RR3031.1","volume":"178","author":"D Schaue","year":"2012","unstructured":"Schaue D, Kachikwu EL, McBride WH. Cytokines in radiobiological responses: a review. Radiat Res. 2012;178(6):505\u201323.","journal-title":"Radiat Res"},{"issue":"1","key":"2138_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijrobp.2007.05.078","volume":"70","author":"Y Cao","year":"2008","unstructured":"Cao Y, Pan C, Balter JM, Platt JF, Francis IR, Knol JA, et al. Liver function after irradiation based on computed tomographic portal vein perfusion imaging. Int J Radiat Oncol Biol Phys. 2008;70(1):154\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2138_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijrobp.2012.02.037","volume":"85","author":"Y Cao","year":"2013","unstructured":"Cao Y, Wang H, Johnson TD, Pan C, Hussain H, Balter JM, et al. Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging. Int J Radiat Oncol Biol Phys. 2013;85(1):258\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2138_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijrobp.2017.10.005","volume":"100","author":"I El Naqa","year":"2018","unstructured":"El Naqa I, Johansson A, Owen D, Cuneo K, Cao Y, Matuszak M, et al. Modeling of normal tissue complications using imaging and biomarkers after radiation therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2018;100(2):335\u201343.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2138_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.radonc.2019.03.003","volume":"135","author":"A Prayongrat","year":"2019","unstructured":"Prayongrat A, Kobashi K, Ito YM, Katoh N, Tamura M, Dekura Y, et al. The normal tissue complication probability model-based approach considering uncertainties for the selective use of radiation modality in primary liver cancer patients. Radiother Oncol. 2019;135:100\u20136.","journal-title":"Radiother Oncol"}],"updated-by":[{"DOI":"10.1186\/s13014-023-02212-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000}}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02138-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-022-02138-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02138-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:38:52Z","timestamp":1679863132000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-022-02138-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2138"],"URL":"https:\/\/doi.org\/10.1186\/s13014-022-02138-8","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13014-023-02212-9","asserted-by":"object"}]},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"assertion":[{"value":"19 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13014-023-02212-9","URL":"https:\/\/doi.org\/10.1186\/s13014-023-02212-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of King Chulalongkorn Memorial Hospital and Chulalongkorn University, Thailand (IRB no. 602\/60).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Consent to participate"}},{"value":"The informed consent statement from participants was not applicable due to retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"202"}}